|
Volumn 24, Issue 12, 2006, Pages 1955-1956
|
Aromatase inhibitor withdrawal response in metastatic breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
AROMATASE INHIBITOR;
ASPARTATE AMINOTRANSFERASE;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
GONADORELIN ANTAGONIST;
GOSERELIN;
LETROZOLE;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ADULT;
ANAMNESIS;
ARTICLE;
BONE METASTASIS;
BREAST METASTASIS;
CANCER GRADING;
CANCER LOCALIZATION;
CANCER REGRESSION;
CANCER SIZE;
CANCER STAGING;
CASE REPORT;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
GENE OVEREXPRESSION;
HUMAN;
HUMAN TISSUE;
LIVER BIOPSY;
LIVER FUNCTION TEST;
LIVER METASTASIS;
PARTIAL MASTECTOMY;
PATIENT MONITORING;
PREMENOPAUSE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
STAINING;
TREATMENT DURATION;
TREATMENT RESPONSE;
BONE TUMOR;
BREAST TUMOR;
DRUG RESISTANCE;
LIVER TUMOR;
METASTASIS;
PATHOLOGY;
TUMOR RECURRENCE;
ADULT;
ANTINEOPLASTIC AGENTS, HORMONAL;
BONE NEOPLASMS;
BREAST NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GOSERELIN;
HUMANS;
LIVER NEOPLASMS;
NEOPLASM RECURRENCE, LOCAL;
PREMENOPAUSE;
|
EID: 33646352995
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.03.4108 Document Type: Article |
Times cited : (10)
|
References (10)
|